CompuGroup Medical SE & Co. KGaA (LON:0MSD)
London · Delayed Price · Currency is GBP · Price in EUR | Market Cap | 1.21B +12.9% |
| Revenue (ttm) | 1.09B +5.1% |
| Net Income | 24.64M -18.4% |
| EPS | 0.47 -18.2% |
| Shares Out | n/a |
| PE Ratio | 49.12 |
| Forward PE | n/a |
| Dividend | 0.48 (1.35%) |
| Ex-Dividend Date | Apr 20, 2026 |
| Volume | 968 |
| Open | 41.70 |
| Previous Close | 41.11 |
| Day's Range | 41.44 - 41.70 |
| 52-Week Range | 23.46 - 41.70 |
| Beta | 0.77 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 6, 2026 |
About LON:0MSD
CompuGroup Medical SE & Co. KGaA provides e-health services in Germany, Western and Eastern Europe, North America, and internationally. It operates through Ambulatory Information Systems (AIS), Hospital Information Systems (HIS), and Pharmacy Information Systems (PCS) segments. The Ambulatory Information Systems segment develops and sells practice management software for registered physicians, medical care centers, and physician networks. This segment also offers solutions that cover all essential clinical, administrative, and billing functions... [Read more]
Financial Performance
In 2025, LON:0MSD's revenue was 1.25 billion, an increase of 5.10% compared to the previous year's 1.19 billion. Earnings were 28.24 million, a decrease of -18.37%.
Financial numbers in EUR Financial StatementsNews
CompuGroup Medical SE & Co. KGaA Quarterly report: Q2 2025
CompuGroup Medical SE & Co. KGaA has published its Q2 2025 quarterly earnings report on July 31, 2025.
CompuGroup Medical SE & Co. KGaA Slides: Q2 2025
CompuGroup Medical SE & Co. KGaA has posted slides in relation to its Q2 2025 quarterly earnings report, which was published on July 31, 2025.
EQS-PVR: CompuGroup Medical SE & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQS Voting Rights Announcement: CompuGroup Medical SE & Co. KGaA CompuGroup Medical SE & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the o...
EQS-News: Delisting of CompuGroup Medical to become effective as of 24 June 2025
EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Delisting Delisting of CompuGroup Medical to become effective as of 24 June 2025 19.06.2025 / 11:21 CET/CEST The issuer is solely responsible ...
EQS-News: CompuGroup Medical issues joint reasoned statement recommending shareholders to accept CVC’s public delisting offer
EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Delisting CompuGroup Medical issues joint reasoned statement recommending shareholders to accept CVC’s public delisting offer 06.06.2025 / 14:...
EQS-News: CompuGroup Medical and CVC plan delisting – public delisting offer announced by CVC
EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Delisting CompuGroup Medical and CVC plan delisting – public delisting offer announced by CVC 08.05.2025 / 22:09 CET/CEST The issuer is solely...
EQS-WpÜG: Tender Offer / Target company: CompuGroup Medical SE & Co. KGaA; Bidder: Caesar BidCo GmbH
EQS-WpÜG: Caesar BidCo GmbH / Tender Offer Tender Offer / Target company: CompuGroup Medical SE & Co. KGaA; Bidder: Caesar BidCo GmbH 08.05.2025 / 22:05 CET/CEST Dissemination of an announcement accor...
CompuGroup Medical SE & Co. KGaA Earnings Call Transcript: Q1 2025
Q1 2025 saw modest revenue growth of 1% year over year, driven by recurring revenues, while one-time revenues declined. Adjusted EBITDA and EPS fell, but free cash flow improved significantly. Strategic partnership with CVC Capital Partners was finalized, and full-year guidance for low to mid-single-digit organic growth was confirmed.
CompuGroup Medical SE & Co. KGaA Quarterly report: Q1 2025
CompuGroup Medical SE & Co. KGaA has published its Q1 2025 quarterly earnings report on April 30, 2025.
CompuGroup Medical SE & Co. KGaA Slides: Q1 2025
CompuGroup Medical SE & Co. KGaA has posted slides in relation to its Q1 2025 quarterly earnings report, which was published on April 30, 2025.
EQS-PVR: CompuGroup Medical SE & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQS Voting Rights Announcement: CompuGroup Medical SE & Co. KGaA CompuGroup Medical SE & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the o...
Q1/2025: CompuGroup Medical Faces a Slow Start
CompuGroup Medical started 2025 with a slight revenue increase, a strategic financial boost, and a strong focus on innovation, setting the stage for a promising year ahead. Jetzt den vollständigen Art...
EQS-News: Q1/2025: CompuGroup Medical reports slow start into the year
EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Quarterly / Interim Statement/Quarter Results Q1/2025: CompuGroup Medical reports slow start into the year 30.04.2025 / 07:39 CET/CEST The iss...
EQS-News: Final regulatory approval for voluntary public takeover offer – Strategic partnership between CVC and CompuGroup Medical takes effect upon completion of the offer
EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Tender Offer Final regulatory approval for voluntary public takeover offer – Strategic partnership between CVC and CompuGroup Medical takes ef...
EQS-PVR: CompuGroup Medical SE & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQS Voting Rights Announcement: CompuGroup Medical SE & Co. KGaA CompuGroup Medical SE & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the o...
CompuGroup Medical SE & Co. KGaA Earnings Call Transcript: Q4 2024
2024 saw a strategic shift with new leadership, key acquisitions, and a focus on innovation and recurring revenues. Organic revenue declined 2% year-over-year, but recurring revenues grew 5% and now make up nearly 75% of total revenues. Guidance for 2025 anticipates low- to mid-single digit organic growth and improved free cash flow.
CompuGroup Medical SE & Co. KGaA Annual report: Q4 2024
CompuGroup Medical SE & Co. KGaA has published its Q4 2024 annual report on March 6, 2025.
CompuGroup Medical SE & Co. KGaA Slides: Q4 2024
CompuGroup Medical SE & Co. KGaA has posted slides in relation to its Q4 2024 quarterly earnings report, which was published on March 6, 2025.
CompuGroup Medical: FY 2024 Results Align, Growth Expected in 2025
CompuGroup Medical SE & Co. KGaA faced a revenue dip in 2024 but saw a rise in recurring revenues, underscoring stability. With a focus on AI and innovation, the company eyes growth in 2025. Jetzt den...
CompuGroup Medical Slashes 2024 Dividend to Legal Minimum!
CompuGroup Medical SE & Co. KGaA is steering its financial course towards innovation, opting to slash its 2024 dividend to a mere EUR 0.05 per share, a stark drop from last year's EUR 1.00. Jetzt den ...
EQS-Adhoc: Ad-hoc: CompuGroup Medical SE & Co. KGaA intends to reduce the annual dividend for the financial year 2024 to the legal minimum
EQS-Ad-hoc: CompuGroup Medical SE & Co. KGaA / Key word(s): Dividend Ad-hoc: CompuGroup Medical SE & Co. KGaA intends to reduce the annual dividend for the financial year 2024 to the legal minimum 04-...
EQS-News: Final results of voluntary public takeover offer – CVC has secured 21.85% of total share capital and voting rights of CompuGroup Medical
EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Tender Offer Final results of voluntary public takeover offer – CVC has secured 21.85% of total share capital and voting rights of CompuGroup ...
EQS-News: Successful conclusion of initial acceptance period of CVC offer for CompuGroup Medical – Additional acceptance period from 29 January to 11 February 2025
EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Miscellaneous Successful conclusion of initial acceptance period of CVC offer for CompuGroup Medical – Additional acceptance period from 29 Ja...
EQS-News: CVC exceeds minimum acceptance threshold for voluntary public tender offer for CompuGroup Medical – additional acceptance period expected to commence on 29 January
EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Tender Offer CVC exceeds minimum acceptance threshold for voluntary public tender offer for CompuGroup Medical – additional acceptance period ...
EQS-News: CGM issues joint reasoned statement recommending that shareholders accept CVC's voluntary public takeover offer
EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Miscellaneous CGM issues joint reasoned statement recommending that shareholders accept CVC's voluntary public takeover offer 03.01.2025 / 11:...